CMRX

Chimerix, Inc. Press Releases

$40.48
*  
unch
unch
Get CMRX Alerts
*Delayed - data as of Mar. 2, 2015  -  Find a broker to begin trading CMRX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Chimerix to Announce Fourth Quarter and Year End 2014 Financial Results on March 6, 2015
2/27/2015 4:09:00 PM - GlobeNewswire


Chimerix Provides Update on Anticipated SUPPRESS Enrollment
2/26/2015 7:00:00 AM - GlobeNewswire


Chimerix to Present at the Cowen & Co. 35th Annual Health Care Conference
2/25/2015 1:11:00 PM - GlobeNewswire


Chimerix Presents Update on Preliminary Data From AdVise Study of Brincidofovir for Adenovirus Infection at BMT Tandem Meetings
2/12/2015 8:00:00 AM - GlobeNewswire


ContraVir Pharmaceuticals'' HBV Compound CMX157 Receives Extended Patent Life
2/4/2015 6:00:00 AM - PR Newswire


Chimerix Focusing Efforts on CMV and Adenovirus Pivotal Trials
1/30/2015 6:12:00 PM - GlobeNewswire


Chimerix Receives Notice of Allowance for Brincidofovir Composition of Matter Patent Extending Exclusivity to 2034
1/12/2015 8:30:00 AM - GlobeNewswire


Chimerix Provides Update on Brincidofovir Pivotal Phase 3 AdVise Trial for the Treatment of Adenovirus
1/8/2015 8:30:00 AM - GlobeNewswire


Biocept's Proprietary Oncology Diagnostics to be Offered on America's Choice Provider Network
1/7/2015 8:30:00 AM - GlobeNewswire


Chimerix to Present at the 33rd Annual J.P. Morgan Healthcare Conference
1/7/2015 8:30:00 AM - GlobeNewswire


Chimerix Provides Recap of 2014 Events
12/23/2014 8:30:00 AM - GlobeNewswire


Chimerix and ContraVir Pharmaceuticals Establish Strategic Collaboration for Antiviral Drug Candidate CMX157
12/18/2014 6:00:00 AM - GlobeNewswire


Chimerix Appoints Ronald C. Renaud, Jr. to Board of Directors
12/17/2014 4:30:00 PM - GlobeNewswire